FindTrial
Sign In

Establishment of clinical diagnosis and treatment model of pancreatic ductal adenocarcinoma based on single cell sequencing and multi-omics study

Establishment of clinical diagnosis and treatment model of pancreatic ductal adenocarcinoma based on single cell sequencing and multi-omics study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029404
Enrollment
Unknown
Registered
2020-01-29
Start date
2019-06-01
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Gold Standard:Pathology examination
Index test:diagnosis&#32
and&#32
treatment&#32
model&#32
of&#32
pancreatic&#32
ductal&#32
adenocarcinoma&#32
based&#32
on&#32
single&#32
cell&#32
sequencing&#32
multi-omics&#32
factors

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 18-80 years old patients with new pancreatic ductal adenocarcinoma

Exclusion criteria

Exclusion criteria: 1. Those who with other malignant tumor; 2. Those who had radiotherapy and chemotherapy.

Design outcomes

Primary

MeasureTime frame
Survival time;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactQing Zhu

Department of Abdominal Oncology, West China Hospital, Sichuan University

newzhuqing1972@yahoo.com+86 18009252290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026